Jamie A. Chapman

Jamie A. Chapman

Auto-generated profile, based on publicly available information

Jamie A. Chapman

University of Tasmania

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 July 2008 in Cellular and Molecular Life Sciences
Verified
Journal Article
Closed access
PDF file
JLJ. Y. K. Leung
J. Y. K. Leung
JCJ. A. Chapman
J. A. Chapman
JHJ. A. Harris
J. A. Harris
DHD. Hale
D. Hale
RCRoger Chung
Roger Chung
MCM. I. Chuah
M. I. Chuah

29 May 2012 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
RHRosalind P Herbert
Rosalind P Herbert
JHJulie Harris
Julie Harris
KCKim Pei Chong
Kim Pei Chong
JCJamie Chapman
Jamie Chapman
AWAdrian K West
Adrian K West
MCMeng Inn Chuah
Meng Inn Chuah
Background: The primary olfactory pathway is a potential route through which microorganisms from the periphery could potentially access the central nervous system. Our previous studies demonstrated that if the olfactory epithelium was damaged, bacteria administered into the nasal cavity induced nitric oxide production in olfactory ensheathing cells. This study investigates the cytokine profile of olfactory tissues as a consequence of bacterial challenge and establishes whether or not the bacteria are able to reach the olfactory bulb in the central nervous system. Methods: The olfactory epithelium of C57BL/6 mice was damaged by unilateral Triton X-100 nasal washing, and Staphylococcus aureus was administered ipsilaterally 4 days later. Olfactory mucosa and bulb were harvested 6 h, 24 h and 5 days after inoculation and their cytokine profile compared to control tissues. The fate of S. aureus and the response of bulbar microglia were examined using fluorescence microscopy and transmission electron microscopy. Results: In the olfactory mucosa, administered S. aureus was present in supporting cells of the olfactory epithelium, and macrophages and olfactory nerve bundles in the lamina propria. Fluorescein isothiocyanate-conjugated S. aureus was observed within the olfactory mucosa and bulb 6 h after inoculation, but remained restricted to the peripheral layers up to 5 days later. At the 24-h time point, the level of interleukin-6 (IL-6) and tumour necrosis factor-α in the compromised olfactory tissues challenged with bacteria (12,466 ± 956 pg/ml and 552 ± 193 pg/ml, respectively) was significantly higher than that in compromised olfactory tissues alone (6,092 ± 1,403 pg/ml and 80 ± 2 pg/ml, respectively). Immunohistochemistry confirmed that IL-6 was present in several cell types including olfactory ensheathing cells and mitral cells of the olfactory bulb. Concurrently, there was a 4.4-, 4.5- and 2.8-fold increase in the density of iNOS-expressing cells in the olfactory mucosa, olfactory nerve and glomerular layers combined, and granule layer of the olfactory bulb, respectively. Conclusions: Bacteria are able to penetrate the immunological defence of the compromised olfactory mucosa and infiltrate the olfactory bulb within 6 h even though a proinflammatory profile is mounted. Activated microglia may have a role in restricting bacteria to the outer layers of the olfactory bulb.

20 November 2020
Verified
Book Chapter
Closed access
PDF file
JCJamie A. Chapman
Jamie A. Chapman
LLLisa M. J. Lee
Lisa M. J. Lee
NSNathan T. Swailes
Nathan T. Swailes

28 May 2010 in Cerebral Cortex
Verified
Journal Article
Open access
PDF file
CBCatherine Blizzard
Catherine Blizzard
JCJyoti A. Chuckowree
Jyoti A. Chuckowree
AKAnna E. King
Anna E. King
KHKatherine A. Hosie
Katherine A. Hosie
GMGraeme H. McCormack
Graeme H. McCormack
TDTracey Dickson
Tracey Dickson
Accumulating evidence indicates that damage to the adult mammalian brain evokes an array of adaptive cellular responses and may retain a capacity for structural plasticity. We have investigated the cellular and architectural alterations following focal experimental brain injury, as well as the specific capacity for structural remodeling of neuronal processes in a subset of cortical interneurons. Focal acute injury was induced by transient insertion of a needle into the neocortex of anesthetized adult male Hooded–Wistar rats and thy1 green fluorescent protein (GFP) mice. Immunohistochemical, electron microscopy, and bromodeoxyuridine cell proliferation studies demonstrated an active and evolving response of the brain to injury, indicating astrocytic but not neuronal proliferation. Immunolabeling for the neuron-specific markers phosphorylated neurofilaments, α-internexin and calretinin at 7 days post injury (DPI) indicated phosphorylated neurofilaments and α-internexin but not calretinin immunopositive axonal sprouts within the injury site. However, quantitative studies indicated a significant realignment of horizontally projecting dendrites of calretinin-labeled interneurons at 14 DPI. This remodeling was specific to calretinin immunopositive interneurons and did not occur in a subpopulation of pyramidal neurons expressing GFP in the injured mouse cortex. These data show that subclasses of cortical interneurons are capable of adaptive structural remodeling.

31 August 2023
Verified
Book Chapter
Closed access
PDF file
MHMichael Hortsch
Michael Hortsch
VGVirgínia Cláudia Carneiro Girão-Carmona
Virgínia Cláudia Carneiro Girão-Carmona
ALAna Caroline Rocha de Melo Leite
Ana Caroline Rocha de Melo Leite
INIlias Nikas
Ilias Nikas
NKNii Koney-Kwaku Koney
Nii Koney-Kwaku Koney
JCJamie Chapman
Jamie Chapman

20 June 2007 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
MBM. J. Burnell
M. J. Burnell
MLMark Norman and Hinda Levine
Mark Norman and Hinda Levine
JCJ. A. Chapman
J. A. Chapman
VBV. Bramwell
V. Bramwell
TVT. Vandenberg
T. Vandenberg
KPK. Pritchard
K. Pritchard
550 Background: CEF and AC followed by paclitaxel (AC/T) are commonly used adjuvant regimens in women with early breast cancer. In a trial conducted by the EORTC, NCIC CTG, and SAKK three months of dose-dense EC was equivalent to six months of CEF in women with locally advanced breast cancer. We hypothesized that three months of a taxane following dose-dense EC would be superior to CEF alone or AC/T. The results of a planned interim analysis were presented in San Antonio 2006 (Abstract #53). We now present more detailed results on efficacy and toxicity. Methods: Women 60 years of age or younger, with axillary node positive or high risk node negative breast cancer were randomized to CEF, EC/T or AC/T for six months. Results: Between December 2000 and April 2005, 2104 patients were enrolled. The median follow-up is 30.4 months. Hazard ratios for recurrence are: AC/T vs. CEF, 1.49 (95% CI, 1.12–1.99), p=0.005; AC/T vs. EC/T, 1.68 (95% CI, 1.25–2.27), p=0.0006; and EC/T vs. CEF, 0.89 (95% CI, 0.64–1.22), p=0.46. Three year recurrence-free survival rates for CEF, EC/T, and AC/T are 90.1, 89.5 and 85.0%, respectively. There was no significant interaction between ER status and treatment. Multivariate analysis of predictive factors will be presented. The numbers of deaths are 50 (CEF), 47 (EC/T) and 65 (AC/T). There was more toxicity in CEF and EC/T compared to AC/T. Conclusion: AC/T given every three weeks, although less toxic is significantly inferior to CEF or EC/T in terms of relapse-free survival. It is too early to detect any difference between CEF and dose-dense EC/T. Our results indicate that there is still room to explore anthracycline and taxane adjuvant chemotherapy regimens. Supported by: NCI Canada and Canadian Cancer Society, Pfizer, Bristol-Myers Squibb, Amgen, Janssen Ortho, Ortho Biotech, and NCI US. [Table: see text] No significant financial relationships to disclose.